Long-term outcome of pancreatic function following oncological surgery in children: Institutional experience and review of the literature

Table 2 Main demographic and clinical characteristics of our patients

No.	Sex	Age	Histology	Symptoms	Tumor site	Type of surgery	Length of follow-up	Exocrine pancreatic failure	Endocrine pancreatic failure	Vitamin D insufficiency
1	F	12	SPT	Weight loss	HEAD	PPPD	10.4 yr	Yes	Yes	Yes
2	M	9.8	SPT	Occasional diagnosis	BODY	Distal Pancreatectomy	6.4 yr	No	No	No
3	F	17.3	SPT	AP	HEAD	PPPD	3.9 yr	Yes	No	Yes
4	M	15.5	Neuroendocrine tumor	AP	HEAD	PPPD	2.3 yr	No	No	No
5	F	6.6	Acinar cell carcinoma	AP+ weight loss	HEAD	PPPD	11.5 yr	Yes	Yes	Yes
6	M	4.11	Acinar cell carcinoma	Not available	HEAD	PD	12.3 yr	Yes	No	Yes
7	F	14.3	SPT	Weight loss	TAIL	Distal Pancreatectomy	2 yr	No	No	Yes
8	F	13.2	SPT	AP	HEAD	PPPD	9 mo	No	No	Yes
9	F	3 mo	Insulinoma	Hypoglycemia	HEAD	Cephalic Pancreatectomy	11 yr	No	No	Yes
10	F	11	SPT	AP	BODY/TAIL	Distal Splenopancreatectomy	2 yr	No	No	No
11	M	10	Neuroendocrine tumor	Screening in Tuberous Sclerosis	BODY/TAIL	Distal Pancreatectomy	9 yr	No	No	No
12	F	15.5	SPT	No symptoms	BODY/TAIL	Distal Splenopancreatectomy	2.5 yr	No	No	No
13	F	13.8	SPT	AP	HEAD	PPPD	10 yr	No	No	No
14	F	11.6	SPT	No symptoms	BODY/TAIL	Distal Splenopancreatectomy	3.4 yr	No	No	Yes
15	F	16.2	SPT	AP+ weight loss	TAIL	Distal Pancreatectomy	3.8 yr	No	No	No
16	F	7 mo	Insulinoma	Hypoglycemia	HEAD	PPPD	1 mo	No	No	No

F: Female; M: Male; Age: Years at diagnosis; SPT: Solid pseudopapillary tumor; AP: Abdominal pain; PD: Pancreaticoduodenectomy; PPPD: Pylorus preserving pancreaticoduodectomy; Vitamin D insufficiency: < 30 ng/mL.